Evidence map›Paper›PMID 40609641›Full record

ArticleMucosal immunology2025

Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection.

Daichi Nonaka, Soichiro Yoshida, Kenta Nakano, Xiaojun Li, Tadashi Okamura, Eiji Umemoto, Taisho Yamada, Miyuki Watanabe, Shozo Jinno, Minako Ito and 5 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Macrophages conquer the glands.Nature immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daichi NonakaDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Soichiro YoshidaDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Kenta NakanoDepartment of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine (NCGM), Tokyo 162-8655, Japan.
Xiaojun LiDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan; The Second Xiangya Hospital of Central South University, department of gastroenterology, Changsha, Hunan 410000, China.
Tadashi OkamuraDepartment of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine (NCGM), Tokyo 162-8655, Japan.
Eiji UmemotoLaboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Taisho YamadaDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Miyuki WatanabeDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Shozo JinnoDepartment of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Minako ItoDivision of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Makoto TsudaDepartment of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Naoto NoguchiDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Jean X JiangDepartment of Biochemistry and Structural Biology, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.
Eriko SumiyaDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Shinichiro SawaDivision of Mucosal Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan. Electronic address: sawa@bioreg.kyushu-u.ac.jp.

Funding

CSF-1 Gene Expression in Osteoclast BiologyR01AG045040 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JIANG, JEAN X · 2013 to 2017
$1.5M
NIA NIH HHS R01 AG045040
6 · The paper itself

Abstract

Macrophages play essential roles in immune defense and tissue homeostasis, but the mechanisms underlying their colonization in the gut mucosa remain incompletely understood. Here, we identify CSF1, primarily derived from fibroblasts, as the dominant factor maintaining mucosal macrophage colonization, whereas IL-34 deficiency alone has a minimal impact. We reveal that CSF1R ligands originate from distinct cellular sources: macrophages at the upper villus region depend on fibroblast-derived CSF1 and IL-34, while macrophages in the lower villus and the submucosal (lower villus + SM) region are regulated by CSF1 from both fibroblasts and endothelial cells. Additionally, within the lower villus + SM region, CSF1-producing CD81

Indexed as

FibroblastsIntestinal MucosaMacrophage Colony-Stimulating FactorMacrophagesSalmonella InfectionsSalmonella typhimuriumAnimalsCells, CulturedInterleukinsMiceMice, Inbred C57BLMice, KnockoutCSF1 protein, mouseinterleukin-34, mouseInterleukinsMacrophage Colony-Stimulating FactorCSF1FibroblastIL-34IntestineMacrophageNiche

Identifiers

PMID40609641
PMCPMC13242209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.